149 related articles for article (PubMed ID: 27134758)
1. TRIP6 antagonizes the recruitment of A20 and CYLD to TRAF6 to promote the LPA2 receptor-mediated TRAF6 activation.
Lin FT; Lin VY; Lin VT; Lin WC
Cell Discov; 2016; 2():15048-. PubMed ID: 27134758
[TBL] [Abstract][Full Text] [Related]
2. The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration.
Lai YJ; Lin VT; Zheng Y; Benveniste EN; Lin FT
Mol Cell Biol; 2010 Dec; 30(23):5582-96. PubMed ID: 20876301
[TBL] [Abstract][Full Text] [Related]
3. c-Src-mediated phosphorylation of TRIP6 regulates its function in lysophosphatidic acid-induced cell migration.
Lai YJ; Chen CS; Lin WC; Lin FT
Mol Cell Biol; 2005 Jul; 25(14):5859-68. PubMed ID: 15988003
[TBL] [Abstract][Full Text] [Related]
4. PTPL1/FAP-1 negatively regulates TRIP6 function in lysophosphatidic acid-induced cell migration.
Lai YJ; Lin WC; Lin FT
J Biol Chem; 2007 Aug; 282(33):24381-7. PubMed ID: 17591779
[TBL] [Abstract][Full Text] [Related]
5. TRIP6 promotes inflammatory damage via the activation of TRAF6 signaling in a murine model of DSS-induced colitis.
Yang Y; Li XM; Wang JR; Li Y; Ye WL; Wang Y; Liu YX; Deng ZY; Gan WJ; Wu H
J Inflamm (Lond); 2022 Jan; 19(1):1. PubMed ID: 34983535
[TBL] [Abstract][Full Text] [Related]
6. Increased A20-E3 ubiquitin ligase interactions in bid-deficient glia attenuate TLR3- and TLR4-induced inflammation.
Kinsella S; Fichtner M; Watters O; König HG; Prehn JHM
J Neuroinflammation; 2018 May; 15(1):130. PubMed ID: 29720226
[TBL] [Abstract][Full Text] [Related]
7. TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways.
Li L; Bin LH; Li F; Liu Y; Chen D; Zhai Z; Shu HB
J Cell Sci; 2005 Feb; 118(Pt 3):555-63. PubMed ID: 15657077
[TBL] [Abstract][Full Text] [Related]
8. Competition between TRAF2 and TRAF6 regulates NF-kappaB activation in human B lymphocytes.
Zhang W; Zhang X; Wu XL; He LS; Zeng XF; Crammer AC; Lipsky PE
Chin Med Sci J; 2010 Mar; 25(1):1-12. PubMed ID: 20449947
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells.
Saatian B; Zhao Y; He D; Georas SN; Watkins T; Spannhake EW; Natarajan V
Biochem J; 2006 Feb; 393(Pt 3):657-68. PubMed ID: 16197369
[TBL] [Abstract][Full Text] [Related]
10. Proinflammatory mediators alter expression of nuclear factor kappa B-regulating deubiquitinases in sinonasal epithelial cells.
Li P; Wang Y; Turner JH
Int Forum Allergy Rhinol; 2015 Jul; 5(7):583-9. PubMed ID: 25907801
[TBL] [Abstract][Full Text] [Related]
11. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
12. TRAF6 negatively regulates TNFalpha-induced NF-kappaB activation.
Funakoshi-Tago M; Kamada N; Shimizu T; Hashiguchi Y; Tago K; Sonoda Y; Kasahara T
Cytokine; 2009 Feb; 45(2):72-9. PubMed ID: 19091594
[TBL] [Abstract][Full Text] [Related]
13. BCL3 regulates RANKL-induced osteoclastogenesis by interacting with TRAF6 in bone marrow-derived macrophages.
Wang K; Li S; Gao Y; Feng X; Liu W; Luo R; Song Y; Ji Tu ; Liu Y; Yang C
Bone; 2018 Sep; 114():257-267. PubMed ID: 29933112
[TBL] [Abstract][Full Text] [Related]
14. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.
Shembade N; Harhaj NS; Liebl DJ; Harhaj EW
EMBO J; 2007 Sep; 26(17):3910-22. PubMed ID: 17703191
[TBL] [Abstract][Full Text] [Related]
15. TRIP6 regulates the proliferation, migration, invasion and apoptosis of osteosarcoma cells by activating the NF-κB signaling pathway.
Liu W; Cheng L; Li Q; Jing J
Exp Ther Med; 2020 Mar; 19(3):2317-2325. PubMed ID: 32104300
[TBL] [Abstract][Full Text] [Related]
16. Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).
Azpilikueta A; Bolaños E; Lang V; Labiano S; Aznar MA; Etxeberria I; Teijeira A; Rodriguez-Ruiz ME; Perez-Gracia JL; Jure-Kunkel M; Zapata JM; Rodriguez MS; Melero I
Oncoimmunology; 2017; 7(1):e1368605. PubMed ID: 29296520
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of TLR4- and -7-induced NF kappa B1 p105-TPL2-ERK pathway to TNF-receptor-associated-factor-6 revealed by RNAi in mouse macrophages.
Loniewski KJ; Patial S; Parameswaran N
Mol Immunol; 2007 Jul; 44(15):3715-23. PubMed ID: 17507094
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
19. Distinct roles of TRAF6 and TAK1 in the regulation of adipocyte survival, thermogenesis program, and high-fat diet-induced obesity.
Gallot YS; McMillan JD; Xiong G; Bohnert KR; Straughn AR; Hill BG; Kumar A
Oncotarget; 2017 Dec; 8(68):112565-112583. PubMed ID: 29348847
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
